Exhibit
2.1
AGREEMENT AND PLAN OF
MERGER
BY AND AMONG
NEUTRON ENTERPRISES, INC.
AND NEUTRON ACQUISITION CORP.
AND MARK BROOKSHIRE
AND
STOCK-TRAK, INC.
November 29, 2006
AGREEMENT AND PLAN OF
MERGER
This Agreement and Plan of
Merger (this “ Agreement ”) is entered into as
of November 29, 2006 by and among Neutron Enterprises, Inc., a
Nevada corporation (the “ Parent ”), Neutron
Acquisition Corp., a Delaware corporation and a wholly-owned
subsidiary of the Parent (the “ Transitory Subsidiary
” or “ Buyer ”), Stock-Trak, Inc., a
Georgia corporation (the “ Company ”), and Mr.
Mark Brookshire, (the “ Seller ”).
This Agreement contemplates a
reorganization and merger of the Company with and into the
Transitory Subsidiary within the meaning of Section 368(a) of the
Code. In such merger (the “ Merger ”), the
Seller will receive cash and common stock of the Parent in exchange
for his capital stock of the Company.
The Boards of Directors and
the shareholders of Buyer and the Company have adopted and approved
this Agreement and the Merger and the transactions contemplated
hereby and thereby.
Unless defined elsewhere
herein, capitalized terms shall have the meanings set forth in
Article III hereof.
Now, therefore, in
consideration of the representations, warranties and covenants
herein contained and other good and valuable consideration the
receipt and sufficiency of which is hereby acknowledged, the
Parties agree as follows.
1.1
The Merger . Upon and subject to the terms and conditions of
this Agreement, the Company shall merge with and into the
Transitory Subsidiary at the Effective Time. From and after the
Effective Time, the separate corporate existence of the Company
shall cease and the Transitory Subsidiary shall continue as the
Surviving Corporation. The Merger shall have the effects set forth
in Section 259 of the Delaware General Corporation Law and
Section 14-2-1106 of the Georgia Business Corporations
Act.
1.2
Merger Consideration . In consideration of the Seller and
the Company agreeing to the Merger, the Parent shall pay to the
Seller the amount of Two Million Dollars ($2,000,000), less an
amount equal to the aggregate of the Option Payments, the
Transaction Expenses and the Payoff Amount (the Option Payments,
Transaction Expenses and Payoff Amount are collectively referred to
as, the “ Directed Closing Payments ”), in cash
and the Parent Shares, payable as set forth below and as may be
adjusted by the Adjusted Amount.
In the event that the total
assets of the Company (including any receivables owed by Parent to
the Company) less the total liabilities of the Company (including
any deferred revenue and excluding any liabilities for the Directed
Closing Payments, as of the Effective Time, as determined in
accordance with GAAP applied on a consistent basis with the
Company’s past practices, as reasonably and in good faith
agreed to by the Parties or, failing such agreement, as determined
by arbitration pursuant to the provisions of Section 6.2
hereof, is less than or more than $150,000, the Purchase Price
shall be reduced or increased, as applicable, by an amount (the
“ Adjustment Amount ”) equal to the amount of
such deficit (the “ Deficit ”) or overage (the
“ Overage ”), as the case may be. Prior to the
Closing, the Parties, acting reasonably and in good faith, shall
attempt to agree upon the Adjustment Amount (the “
Estimated Adjustment Amount ”). Once the Adjustment
Amount is determined, the Cash Consideration shall be reduced or
increased, as applicable, and the appropriate adjustment shall be
paid by the Seller to the Parent or by the Parent to the Seller, as
the case may be, within 10 days from the determination of the
amount thereof. In determining the Adjustment Amount, liabilities
for the Directed Closing Payments shall not be included in the
liabilities of the Company.
- 2-
1.3
Payments at Closing . At Closing:
(a) Parent
shall, or shall cause Buyer to, pay Seller, as the sole shareholder
of the Company, an amount equal to Two Million Dollars
($2,000,000.00), less the Estimated Adjustment Amount (in the case
of a Deficit) or plus the Estimated Adjustment Amount (in the case
of an Overage), and less the Directed Closing Payments, (the
“ Cash Consideration ”) by wire transfer of
immediately available funds at the Closing;
|
(b) Parent
shall issue to Seller, as the sole shareholder of the Company, the
Parent Shares. The said shares shall be “restricted
securities”, as that term is defined under the Securities Act
and the rules thereunder; and
|
(c) Parent
shall, or shall cause Buyer to, pay, on behalf of the Company, an
aggregate amount equal to the Option Payments to the Option Holders
specified on Schedule I to be delivered by the Company on or before
the Closing Date in the amounts set forth therein, by wire transfer
of immediately available funds at the Closing, less the tax
withholdings as permitted by Section 1.8.
|
(d) Pay,
on behalf of the Company, to one of more accounts designated in
writing by the Company, an aggregate amount equal to the Payoff
Amount.
|
(e) Parent
shall, or shall cause the Buyer to, pay, on behalf of the Company,
to one of more accounts designated in writing by the Company, an
aggregate amount equal to the Transaction Expenses known at such
time.
|
1.4
The Closing . The Closing shall take place at the offices of
the Buyer’s attorneys commencing at 10:00 a.m. local
time on the Closing Date.
1.5
Actions at the Closing . At the Closing:
(a) the
Company and/or the Seller shall deliver to the Buyer the various
certificates, instruments and documents referred to in
Section 5.1;
|
(b) the
Buyer shall deliver to the Company the various certificates,
instruments and documents referred to in
Section 5.2;
|
- 3 -
(c) the
Seller shall deliver to the Buyer the certificate(s) representing
his Company Shares, duly endorsed for transfer;
|
(d) the
Parent or Buyer shall make the cash payments contemplated by
Section 1.3 to the respective parties set forth therein, and
Parent or its transfer agent shall deliver the Parent Shares to and
in the name of the Seller;
|
(e) the
Surviving Corporation shall file the Certificate of Merger with the
Secretary of State of the State of Delaware and the Secretary of
State of the State of Georgia.
|
1.6
Additional Action . The Transitory Subsidiary may, at any
time after the Closing, take any action, including executing and
delivering any document, in the name and on behalf of either the
Company or the Transitory Subsidiary, in order to consummate the
transactions contemplated by this Agreement.
|
|
1.7
Conversion of Shares .
|
(a) At
the Effective Time, by virtue of the Merger and without any action
on the part of any party hereto, the shares of the Company’s
capital stock issued and outstanding immediately prior to the
Effective Time shall be converted into and represent the right to
receive the Cash Consideration and the Parent Shares set forth in
Section 1.3 hereof;
|
(b) Each
share of the Company’s capital stock held in the
Company’s treasury immediately prior to the Effective Time
and each share of the Company’s capital stock owned
beneficially by the Transitory Subsidiary shall be cancelled and
retired without payment of any consideration therefore;
|
(c) Each
share of common stock, $.001 par value per share, of the Transitory
Subsidiary issued and outstanding immediately prior to the
Effective Time shall remain issued and outstanding as the capital
stock of the Surviving Corporation;
|
1.8
Options and Warrants . The Company shall take all requisite
action so that, prior to the Closing, all Options shall be
cancelled and all Company Stock Plans shall terminate at the
Effective Time. Parent or the Surviving Corporation shall be
entitled to deduct and withhold from the Option Payments payable
under this Agreement such amounts as may be required to be deducted
or withheld therefrom under (a) the Code or (b) any applicable
state, local or foreign tax laws. To the extent that any amounts
are so deducted and withheld, those amounts shall be treated as
having been paid to the person in respect of whom such deduction or
withholding was made for all purposes under this
Agreement.
|
1.9
No Further Rights . From and after the Effective Time, no
Company Shares other than those held by the Transitory Subsidiary
shall be deemed to be outstanding, and holders of Certificates
shall cease to have any rights with respect thereto, except as
provided herein or by law.
1.10
Release of Claims By the Seller . Effective as of the
Closing Date, and except for any obligations or liabilities arising
out of this Agreement, the Merger or the transactions contemplated
hereby and thereby, the Seller, and his heirs, assigns, agent,
legal representatives and all persons acting by, through or under
them, hereby release the Company and each of its successors,
predecessors, assigns, agents, advisors, officers, directors,
employees, legal representatives, partners and all persons acting
by, through or under each of them, from any and all claims,
obligations, causes of action, actions, suits, contracts,
controversies, agreements, promises, damages, demands, costs,
attorneys’ fees and liabilities of any nature whatsoever from
the beginning of time up to and including the Closing Date, in law
or at equity, whether known now or on the Closing Date or unknown,
anticipated or unanticipated, suspected or claimed, fixed or
contingent, liquidated or unliquidated, arising out of, in
connection with or relating to any matter, cause or thing
whatsoever.
- 4 -
|
|
1.11
Certificate of Incorporation and By-laws .
|
(a)
The Certificate of Incorporation of the Surviving Corporation
immediately following the Effective Time shall be the same as the
Certificate of Incorporation of the Transitory Subsidiary
immediately prior to the Effective Time, except that (i) the name
of the corporation set forth therein shall be changed to the name
of the Company and (ii) the identity of the incorporator shall be
deleted;
(b)
The By-laws of the Surviving Corporation immediately following the
Effective Time shall be the same as the By-laws of the Transitory
Subsidiary immediately prior to the Effective Time, except that the
name of the corporation set forth therein shall be changed to the
name of the Company.
1.12
Closing of Transfer Books . At the Effective Time, the stock
transfer books of the Company shall be closed and no transfer of
shares of the Company’s capital stock shall thereafter be
made.
|
ARTICLE
II
REPRESENTATIONS AND WARRANTIES OF THE SELLER
|
To induce the Buyer to enter
into this Agreement and to consummate the transactions contemplated
hereby, the Seller represents and warrants to and covenants with
the Buyer that, except as set forth in the Disclosure Schedule, the
statements contained in this Article II are true and correct
as of the date of this Agreement and will be materially true and
correct as of the Closing as though made as of the Closing Date,
except to the extent such representations and warranties are
specifically made as of a particular date (in which case such
representations and warranties will be true and correct as of such
date). The Disclosure Schedule shall be arranged in sections and
subsections corresponding to the numbered and lettered sections and
subsections contained in this Article II. The disclosures in any
section or subsection of the Disclosure Schedule shall qualify only
the corresponding section or subsection in this Article II, unless
it is reasonably apparent that such disclosure relates to another
section or subsection of this Agreement. For purposes of this
Article II, the phrase “to the knowledge of the
Company” or any phrase of similar import shall be deemed to
refer to the actual knowledge of the Seller, as well as any other
knowledge which the Seller would have possessed had he made
reasonable inquiry of appropriate employees of the Company, with
respect to the matter in question.
- 5 -
2.1
Organization, Qualification and Corporate Power . The
Company is a corporation duly organized, validly existing and in
good standing under the laws of the State of Georgia. The Company
is duly qualified to conduct business and is in corporate and tax
good standing under the laws of each jurisdiction listed in
Section 2.1 of the Disclosure Schedule, which jurisdictions
constitute the only jurisdictions in which the nature of the
Company's businesses or the ownership or leasing of its properties
requires such qualification, except for those jurisdictions in
which the failure to be so qualified or in good standing,
individually or in the aggregate, has not had and would not
reasonably be expected to have a Company Material Adverse Effect.
The Company has all requisite corporate power and authority to
carry on the businesses in which it is engaged and to own and use
the properties owned and used by it. The Company has furnished to
the Buyer complete and accurate copies of its Certificate of
Incorporation and by-laws. The Company is not in default under or
in violation of any provision of its Certificate of Incorporation
or by-laws.
(a) The
authorized capital stock of the Company consists of 10,000,000
Common Shares, of which, as of the date of this Agreement,
9,000,000 shares are issued and outstanding;
|
(b) Section 2.2
of the Disclosure Schedule sets forth a complete and accurate list,
as of the date of the Agreement, of the holders of capital stock of
the Company, showing the number of shares of capital stock, and the
class or series of such shares, held by each stockholder and (for
shares other than Common Stock) the number of Common Shares (if
any) into which such shares are convertible. Section 2.2 of
the Disclosure Schedule also indicates all outstanding Common
Shares that constitute Restricted Stock or that are otherwise
subject to a repurchase or redemption right, indicating the name of
the applicable stockholder, the vesting schedule (including any
acceleration provisions with respect thereto), and the repurchase
price payable by the Company. All of the issued and outstanding
shares of capital stock of the Company have been duly authorized
and validly issued and are fully paid and non-assessable. All of
the issued and outstanding shares of capital stock of the Company
have been offered, issued and sold by the Company in compliance
with all applicable federal and state securities laws, if
applicable;
|
(c) Except
as set forth in Section 2.2 of the Disclosure Schedule, there
are not now and have never been any Company Stock Plans;
|
(d) Except
as set forth in Section 2.2 of the Disclosure Schedule, (i) no
subscription, warrant, option, convertible security or other right
(contingent or otherwise) to purchase or acquire any shares of
capital stock of the Company is authorized or outstanding, (ii) the
Company has no obligation (contingent or otherwise) to issue any
subscription, warrant, option, convertible security or other such
right, or to issue or distribute to holders of any shares of its
capital stock any evidences of indebtedness or assets of the
Company (iii) the Company has no obligation (contingent or
otherwise) to purchase, redeem or otherwise acquire any shares of
its capital stock or any interest therein or to pay any dividend or
to make any other distribution in respect thereof, and (iv) there
are no outstanding or authorized stock appreciation, phantom stock
or similar rights with respect to the Company;
|
- 6 -
(e) Except
as set forth in Section 2.2 of the Disclosure Schedule, there
is no agreement, written or oral, between the Company and any
holder of its securities, or among any holders of its securities,
relating to the sale or transfer (including agreements relating to
rights of first refusal, co-sale rights or “drag-along”
rights), or voting of the capital stock of the Company;
|
(f) The
Seller is the record and beneficial owners of 9,000,000 shares of
Company Common Stock, and will be at Closing, the record and
beneficial owner of 9,000,000 shares of Company Common Stock, which
will represent at the Closing 100% of the Company’s
outstanding capital stock, free and clear of all claims, liens,
hypothecs, prior claims, options, agreements, restrictions and
encumbrances whatsoever.
|
2.3
Authorization of Transaction . The Company has all requisite
power and authority to execute and deliver this Agreement and to
perform its obligations hereunder. The execution and delivery by
the Company of this Agreement and the consummation by the Company
of the transactions contemplated hereby have been duly and validly
authorized by all necessary corporate action on the part of the
Company. Without limiting the generality of the foregoing, the
Board of Directors of the Company, at meetings duly called and
held, by the unanimous vote of all directors (i) determined
that the transactions contemplated hereby are fair and in the best
interests of the Company and its stockholders, (ii) adopted
this Agreement in accordance with the provisions of the Act, and
(iii) directed that this Agreement be submitted to the
stockholders of the Company for their adoption and approval with a
recommendation that the stockholders of the Company vote in favor
of the adoption of this Agreement and the approval of the
transactions contemplated hereby and thereby. This Agreement has
been duly and validly executed and delivered by the Company and
constitutes a valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms,
subject to bankruptcy, insolvency, fraudulent transfer,
reorganization, moratorium and other similar laws of generally
applicability relating to or affecting creditors’ rights and
to general equity principles.
- 7 -
2.4
Non-contravention . Other than as set forth on Schedule 2.4,
neither the execution and delivery by the Seller or the Company of
this Agreement, nor the consummation by the Seller or the Company
of the transactions contemplated hereby, will (a) conflict
with or violate any provision of the Articles of Incorporation or
By-laws of the Company, (b) require on the part of the Seller
or the Company any notice to or filing with, or any permit,
authorization, consent or approval of, any Governmental Entity,
(c) conflict with, result in a breach of, constitute (with or
without due notice or lapse of time or both) a default under,
result in the acceleration of obligations under, create in any
party the right to terminate, modify or cancel, or require any
notice, consent or waiver under, any contract or instrument to
which the Seller or the Company is a party or by which the Seller
or the Company is bound or to which any of the Company’s
assets are subject, except for (i) any conflict, breach,
default, acceleration, termination, modification or cancellation
which, individually or in the aggregate, would not have a Company
Material Adverse Effect and would not adversely affect the
consummation of the transactions contemplated hereby or
(ii) any notice, consent or waiver the absence of which,
individually or in the aggregate, would not have a Company Material
Adverse Effect and would not adversely affect the consummation of
the transactions contemplated hereby, (d) result in the
imposition of any Security Interest upon any assets of the Company
or (e) violate any order, writ, injunction, decree, statute,
rule or regulation applicable to the Seller or the Company or any
of their properties or assets.
2.5
Subsidiaries . The Company does not have, and has never had,
any Subsidiaries.
2.6
Financial Statements . The
Company has provided to the Buyer the Financial Statements. The
Financial Statements have been prepared in accordance with GAAP,
and the accounting policies of the Company applied on a consistent
basis throughout the periods covered thereby, fairly present, in
all material respects, the financial condition and results of
operations of the Company as of the respective dates thereof and
for the periods referred to therein and are consistent with the
books and records of the Company; provided , however
, that the Financial Statements are subject to normal recurring
year-end adjustments (which will not be material). The Company
shall continue to provide the Buyer through the Closing Date
interim financial statements prepared in accordance with GAAP,
subject to normal recurring year-end adjustments or adjustments in
connection with the audit (the effect of which will not,
individually or in the aggregate, be materially adverse) and
the absence of notes (that, if presented, would not differ
materially from those included in the Balance Sheet), applied on a
consistent basis, and will fairly reflect in all material respects
the financial condition of the Company as at the dates thereof and
the results of the operations of the Company for the periods then
ended, and will be true and complete and are consistent with the
books and records of the Company.
|
|
2.7
Absence of Certain Changes .
|
(a) Since
the Most Recent Balance Sheet Date, (a) there has occurred no
event or development, which, individually or in the aggregate, has
had, or could reasonably be expected to have in the future, a
Company Material Adverse Effect, and (b) the Company has not
taken any of the actions set forth in paragraphs (a) through
(n) of Section 4.4;
|
- 8 -
(b) Since
the Most Recent Balance Sheet Date, there has not been any:
(i) change in the Company’s authorized or issued capital
stock, retirement, or other acquisition by the Company of any
shares of any such capital stock; (ii) a declaration or
payment of any dividend or other distribution or payment in respect
of shares of capital stock; (iii) amendment to the Articles of
Incorporation or Bylaws of the Company; (iv) increase by the
Company of any bonuses, salaries, or other compensation to any
shareholder, director, officer or (except in the ordinary
course of business) employee or entry into any employment,
severance, or similar agreement with any director, officer,
employee; (v) adoption of, or increase in the payments to or
benefits under, any profit sharing, stock option, bonus, deferred
compensation, savings, insurance, pension, retirement, or other
employee benefit plan for or with any employees of the Company;
(vi) sale (other than sales of inventory in the ordinary
course of business), lease, or other disposition of any asset or
property of the Company or mortgage, pledge, or imposition of any
lien or other encumbrance on any material asset or property of the
Company; (vii) cancellation or waiver of any claims or rights
with a value to the Company in excess of $10,000.00;
(viii) material change in the accounting methods used by the
Company; or (ix) agreement, whether oral or written, by the
Company to do any of the foregoing.
|
2.8
Undisclosed Liabilities . The Company does not have any
liability (whether known or unknown, whether accrued, absolute,
contingent or otherwise, whether liquidated or unliquidated and
whether due or to become due), except for (a) liabilities
shown on the Most Recent Balance Sheet, and (b) liabilities
which have arisen since the Most Recent Balance Sheet Date in the
Ordinary Course of Business.
(a) The
Company has filed on a timely basis all Tax Returns that it was
required to file, and all such Tax Returns were complete and
accurate in all material respects. The Company has paid on a timely
basis all Taxes that were due and payable. The unpaid Taxes of the
Company for tax periods through the Most Recent Balance Sheet Date
do not exceed the accruals and reserves for Taxes (excluding
accruals and reserves for deferred Taxes established to reflect
timing differences between book and Tax income) set forth on the
Most Recent Balance Sheet. The Company does not have any actual or
potential liability for any Tax obligation of any taxpayer
(including any affiliated group of corporations or other entities
that included the Company during a prior period) other than the
Company. All Taxes that the Company is or was required by law to
withhold or collect have been duly withheld or collected and, to
the extent required, have been paid to the proper Governmental
Entity. The Company has made adequate and timely installments of
Taxes required to be made;
|
(b) The
Company has delivered to the Buyer complete and accurate copies of
all Tax Returns, examination reports and statements of deficiencies
assessed against or agreed to by the Company for the last six tax
years. No examination or audit of any Tax Return of the Company by
any Governmental Entity is currently in progress or, to the
knowledge of the Company, threatened or contemplated. The Company
has not been informed by any jurisdiction that the jurisdiction
believes that the Company was required to file any Tax Return that
was not filed or that there are taxes due to such jurisdiction. The
Company has not waived any statute of limitations with respect to
Taxes or agreed to an extension of time with respect to a Tax
assessment or deficiency;
|
- 9 -
(c) Except
as may be accrued for on the Most Recent Balance Sheet or as an
accrued liability in determining the Adjustment Amount, there are
no contingent Tax liabilities for unpaid Taxes due and payable
prior to the Closing Date or, to the knowledge of the Seller, any
grounds that could prompt an assessment or reassessment of the
Company in the filing of earlier or current Tax Returns, nor has
the Company received any written notice from any Tax authorities
that an assessment or reassessment of Tax is proposed;
|
(d) Except
for the filings specified in Section 2.9(d) of the Disclosure
Schedule, the Company has not been and is not currently required to
file any Tax Returns or other reports, elections, designations or
filings with any Tax authority located in any jurisdiction outside
the United States of America;
|
(e) The
Company has at all time conducted its business activities on an
arm’s length basis on fair and reasonable terms when entering
into transactions with any shareholder other individual or entity
related to the Company within the meaning of Sections 318, 482 and
958 of the Code;
|
(f) As
of Closing, there will not be any agreement, plan or arrangement,
covering any employee or former employee of the Company that,
individually or collectively, could give rise to the payment of any
amount that would not be deductible by the Company as an expense
under applicable law other than reimbursements of a reasonable
amount of entertainment expenses and other non-deductible expenses
that are commonly paid by similarly situated businesses in
reasonable amounts;
|
(g) The
Company's cost basis, as defined in Section 1012 of the Code, in
respect of its assets is accurately reflected on the Company's Tax
records;
|
(h) The
paid-up capital for Tax purposes for each share of the
Company’s capital stock is no less than its stated par value
for purposes of the Georgia Business Corporations Code;
|
(i) The
Company has made an election to be treated as a Subchapter S
Corporation pursuant to section 1361(a) of the Code. The
foregoing election has been in effect since the date of
incorporation of the Company.
|
(a) At
the Closing, the Company will be the sole, true and lawful owner,
and has good title to, all of the assets (tangible or intangible)
purported to be owned by the Company, free and clear of all
Security Interests. At the Closing, the Company will own or lease
all tangible assets sufficient for the conduct of its businesses as
presently conducted and as presently proposed to be conducted
(without reference to Parent’s business plans for the
Company). Each material tangible asset is free from material
defects, has been maintained in accordance with normal industry
practice, is in good operating condition and repair (subject to
normal wear and tear) and is suitable for the purposes for which it
presently is used;
|
(b) Section 2.10(b)
of the Disclosure Schedule lists individually (i) all fixed
assets (within the meaning of GAAP) of the Company, indicating the
cost, accumulated book depreciation (if any) and the net book value
of each such fixed asset as of the Most Recent Balance Sheet Date,
and (ii) all other assets of a tangible nature (other than
inventories) of the Company whose book value exceeds
$5,000.00;
|
- 10 -
(c) Each
item of equipment, motor vehicle and other asset that the Company
has possession of pursuant to a lease agreement or other
contractual arrangement is in such condition that, upon its return
to its lessor or owner under the applicable lease or contract, the
obligations of the Company to such lessor or owner will have been
discharged in full.
|
2.11
Owned Real Property . The Company does not own and has never
owned any Owned Real Property.
2.12
Real Property Leases . Section 2.12 of the Disclosure
Schedule lists all Leases and lists the term of such Lease, any
extension and expansion options, and the rent payable thereunder.
The Company has delivered to the Buyer complete and accurate copies
of the Leases. With respect to each Lease:
(a) such
Lease is legal, valid, binding, enforceable and in full force and
effect;
|
(b) such
Lease will continue to be legal, valid, binding, enforceable and in
full force and effect immediately following the Closing in
accordance with the terms thereof as in effect immediately prior to
the Closing, subject to bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and other similar laws of
generally applicability relating to or affecting creditors’
rights and to general equity principles;
|
(c) neither
the Company nor, to the knowledge of the Company, any other party,
is in breach or violation of, or default under, any such Lease, and
no event has occurred, is pending or, to the knowledge of the
Company, is threatened, which, after the giving of notice, with
lapse of time, or otherwise, would constitute a breach or default
by the Company or, to the knowledge of the Company, any other party
under such Lease;
|
(d) there
are no disputes, oral agreements or forbearance programs in effect
as to such Lease;
|
(e) the
Company has not assigned, transferred, conveyed, mortgaged, deeded
in trust or encumbered any interest in the leasehold or
subleasehold;
|
(f) to
the knowledge of the Company, all facilities leased or subleased
thereunder are supplied with utilities and other services adequate
for the operation of said facilities; and
|
(g) the
Company is not aware, without independent investigation, of any
Security Interest, easement, covenant or other restriction
applicable to the real property subject to such lease which would
reasonably be expected to materially impair the current uses or the
occupancy by the Company of the property subject
thereto.
|
- 11 -
|
|
2.13
Intellectual Property .
|
(a) Section 2.13(a)
of the Disclosure Schedule lists (i) each patent, patent
application, copyright registration or application therefor, mask
work registration or application therefor, and trademark, service
mark and domain name registration or application therefor of the
Company, (ii) each of the Deliverables of the Company and
(iii) all other material Intellectual Property used in the conduct
of the Company’s business as presently conducted and as
presently proposed to be conducted (without reference to
Parent’s business plans for the Company);
|
(b) At
the Closing, the Company will own or will have the right to use all
Intellectual Property necessary (i) to use, market and license the
Deliverables and (ii) to operate the Internal Systems. Each item of
Company Intellectual Property will be owned or available for use by
the Buyer and the Company immediately following the Closing on
substantially identical terms and conditions as it was immediately
prior to the Closing. The Company has taken all reasonable measures
to protect the proprietary nature of each item of Company
Intellectual Property and to maintain in confidence all trade
secrets and confidential information that it owns or uses. No other
person or entity has any rights to any of the Company Intellectual
Property owned by the Company (except pursuant to agreements or
licenses specified in Section 2.13(b) of the Disclosure
Schedule), and, to the knowledge of the Company, no other person or
entity is infringing, violating or misappropriating any of the
Company Intellectual Property;
|
(c) None
of the Intellectual Property as used by the Company, or the
marketing, distribution, provision or use thereof, infringes or
violates, or constitutes a misappropriation of, any Intellectual
Property rights of any person or entity. None of the Internal
Systems, or the use thereof, infringes or violates, or constitutes
a misappropriation of, any Intellectual Property rights of any
person or entity. Section 2.13(c) of the Disclosure Schedule
lists any complaint, claim or notice, or written threat thereof,
received by the Company alleging any such interference,
infringement, violation or misappropriation; and the Company has
provided to the Buyer complete and accurate copies of all written
documentation in the possession of the Company relating to any such
complaint, claim, notice or threat. The Company has provided to the
Buyer complete and accurate copies of all written documentation in
the Company’s possession relating to claims or disputes known
to the Company concerning any Company Intellectual
Property;
|
(d) Section 2.13(d)
of the Disclosure Schedule identifies each license or other
agreement pursuant to which the Company has licensed, distributed
or otherwise granted any rights to any third party with respect to,
any Company Intellectual Property. Except as described in
Section 2.13(d) of the Disclosure Schedule, the Company has
not agreed to indemnify any person or entity against any
infringement, violation or misappropriation of any Intellectual
Property rights;
|
(e) Section 2.13(e)
of the Disclosure Schedule identifies each item of Company
Intellectual Property that is owned by a party other than the
Company and the license or agreement pursuant to which the Company
uses it (excluding off-the-shelf software programs licensed by the
Company pursuant to “shrink wrap” licenses (“
Off-the-Shelf Software ”));
|
- 12 -
(f) All
of the copyrightable materials incorporated in or bundled with the
Deliverables have been created by employees of the Company within
the scope of their employment by the Company or by independent
contractors of the Company, and the current employees of the
Company have executed agreements expressly assigning all right,
title and interest in such copyrightable materials to the
Company;
|
(g) To
the knowledge of the Company, the Deliverables and the Internal
Systems are free from significant defects or programming errors and
conform in all material respects to the written documentations and
the specifications therefore, to the extent that they
exist;
|
(h) Except
as set forth on Section 2.13(h) of the Disclosure Schedule, at
the time of the Closing, (A) the Company will own all right, title
and interest in, or will have a valid and binding license to use,
the Intellectual Property, and, to the extent required in
connection with the way in which the Company has conducted its
business, to make, have made, use, sell, import and export,
distribute, publicly perform, publicly display, reproduce and
prepare derivative works or otherwise exploit the Intellectual
Property as currently utilized in its business operations; (B) the
rights of the Company to the Intellectual Property will be free and
clear of all Security Interests; (C) all registrations with and
applications to governmental or regulatory bodies in respect of the
Intellectual Property are valid and in full force and effect, and
the Company has taken all action required to maintain their
validity and effectiveness; (D) with respect to the Company’s
licensed Intellectual Property, other than Off-the-Shelf Software,
there are no restrictions on the direct or indirect (i) transfer of
any license, or any interest therein, held by the Company or (ii)
changes of control of the Company; (E) the Company has taken
reasonable measures to protect the secrecy, confidentiality and
value of its trade secrets; (F) the Company will deliver to the
Buyer any existing documentation with respect to any design,
computer program or other know-how or trade secret included in the
Intellectual Property, which documentation, to the best of the
Company’s knowledge, is accurate in all material respects,
and (F) the Company is not, nor has it received any notice that it
is, in default (or with the giving of notice or lapse of time or
both, would be in default) under any license with respect to the
Intellectual Property;
|
(i) Except
as identified on Section 2.13(i) of the Disclosure Schedule,
no approval or consent of any person is needed so that the interest
of the Company in the Intellectual Property shall continue to be in
full force and effect following the transactions contemplated by
this Agreement, and the Company is not subject to any restriction,
agreement, instrument, order, judgment or decree which would be
violated or breached by the consummation of the transactions
contemplated by this Agreement;
|
(j) Except
for the fees identified in Section 2.13(j) of the Disclosure
Schedule for the agreements identified therein, no licensing fees,
royalties or payments are due or payable by the Company in
connection with the Intellectual Property, other than maintenance
fees, if any;
|
(k) Other
than as identified in Section 2.13(k) of the Disclosure
Schedule, the Company has kept secret and has not disclosed the
source code for its Software to any person or entity other than
certain employees or independent contractors of the Company who are
subject to the terms of a binding confidentiality agreement with
respect thereto. The Company has taken reasonable measures to
protect the confidentiality and proprietary nature of its Software,
including without limitation, the use of the confidentiality
agreements with all of its employees or independent contractors
having access to its Software source and object code;
|
- 13 -
(l) No
employee of the Company is in default under, and the consummation
of the transactions contemplated by this Agreement will not result
in a default of, any term of any employment contract, agreement or
arrangement relating to the Software or any non-competition
arrangement, or any other agreement or any restrictive covenant
relating to the Software or its development or exploitation. Other
than as identified in Section 2.13(l) of the Disclosure
Schedule the Company does not have any obligation to compensate any
person for the development, use, sale or exploitation of the
Software, nor has the Company granted to any other person or entity
any license, option or other rights to develop, use, sell or
exploit in any manner the Software whether requiring the payment of
royalties or not;
|
(m) All
Intellectual Property owned by the Company and for which
confidentiality is appropriate has been maintained in confidence in
accordance with protection procedures believed by the Company to be
adequate for protection customarily used in the industry to protect
rights of like importance. All current and former employees who
have authored, co-authored or otherwise contributed to or
participated in any material way in the conception and development
of Intellectual Property which is used in and material to the
Company’s business (“ IP Participant ”)
have executed and delivered to the Company a proprietary
information agreement, pursuant to which, inter alia, such IP
Participant has assigned any and all of his rights in such IP to
the Company and has agreed to keep such IP confidential and not to
use such IP for any purpose unrelated to his work for the Company.
No former or current IP Participant has filed, asserted in writing
or, to the knowledge of the Company (or management employees of the
Company with direct responsibility for Intellectual Property
matters), threatened any claim against the Company in connection
with his involvement in Intellectual Property which is used in the
Company’s business. To the knowledge of the Company (or
management employees of the Company with direct responsibility for
Intellectual Property matters), no IP Participant has any patents
issued or applications pending for any device, process, design or
invention of any kind now used or needed by the Company, which
patents or applications have not been assigned to the
Company;
|
(n) With
respect to privacy and security agreements and other privacy
contractual commitments (the “ Commitments ”),
(A) the Company is in full compliance with all applicable
Commitments; (B) the transactions contemplated by this Agreement
will not violate any Commitments; (C) the Company has not received
inquiries from any other federal or state governmental agencies
regarding Commitments; (D) the Company has not received any written
(including email) complaints regarding Commitments, or compliance
with Commitments; (E) the Commitments have not been rejected by any
applicable certification organization which has reviewed such
Commitment or to which any such Commitment has been submitted, and
(F) the Company has not experienced the cancellation, termination
or revocation of any privacy or security certification issued by
any Commitments;
|
- 14 -
|
|
2.14
Accredited Investor; Investment Intent; Access to Information;
Restrictions on Transfer .
|
(a)
Seller is an “accredited investor” as that term is
defined in Rule 501(a) of Regulation D under the Securities Act.
The Parent Shares are being acquired for the Seller’s own
account for investment purposes only, not as a nominee or agent and
not with a view to the resale or distribution of any part thereof,
and Seller has no present intention of selling, granting any
participation in or otherwise distributing the same and Seller does
not have any contract, undertaking, agreement or arrangement with
any person to sell, transfer or grant participation to such person
or third person with respect to any of the Parent Shares. Seller
acknowledges that it has had access to and has reviewed all
documents and records relating to the Parent, including, but not
limited to, the Parent SEC Reports, that it has deemed necessary in
order to make an informed investment decision with respect to an
investment in the Parent Shares; that it has had the opportunity to
ask representatives of the Parent certain questions and request
certain additional information regarding the finances, operations,
business and prospects of the Parent and has had any and all such
questions and requests answered to its satisfaction; and that it
understands the risks and other considerations relating to an
investment;
(b)
Seller understands that the Parent Shares are “restricted
securities” as such term is defined in Rule 144 under the
Securities Act and have not been registered under the Securities
Act or registered or qualified under any state securities law, and
may not be, directly or indirectly, sold, transferred, offered for
sale, pledged, hypothecated or otherwise disposed of without
registration under the Securities Act and registration or
qualification under applicable state securities laws or the
availability of an exemption therefrom in the opinion of counsel to
Parent;
(a) Section 2.15
of the Disclosure Schedule lists the following agreements (written
or oral) to which the Company is a party as of the date of this
Agreement:
|
|
(i) any
agreement (or group of related agreements) for the lease of
personal property from or to third parties providing for lease
payments having a remaining term longer than twelve months or a
monthly rental amount in excess of $5,000.00;
|
|
(ii) any
agreement (or group of related agreements) for the purchase or sale
of products or for the furnishing or receipt of services (A) which
calls for performance over a period of more than one year, or (B)
in which the Company has granted manufacturing rights, “most
favored nation” pricing provisions or exclusive marketing or
distribution rights relating to any products or territory or has
agreed to purchase a minimum quantity of goods or services or has
agreed to purchase goods or services exclusively from a certain
party;
|
|
(iii) any
agreement concerning the establishment or operation of a
partnership, joint venture or limited liability company;
|
|
(iv) any
agreement (or group of related agreements) in effect as of the
Closing under which it has created, incurred, assumed or guaranteed
(or may create, incur, assume or guarantee) indebtedness (including
capitalized lease obligations) or under which it has imposed (or
may impose) a Security Interest on any of its assets, tangible or
intangible;
|
- 15 -
|
(v) any
agreement for the disposition of any significant portion of the
assets or business of the Company (other than sales of products in
the Ordinary Course of Business) or any agreement for the
acquisition of the assets or business of any other entity (other
than purchases of inventory or components in the Ordinary Course of
Business);
|
|
(vi) any
agreement concerning confidentiality or non-competition, including,
without limitation, those listed in Schedule 2.15(a)(vi) of
the Disclosure Schedule, which shall include, without limitation,
the Employee Covenant Agreements;
|
|
(vii) any
employment or consulting agreement, including any severance,
notice, change of control or similar agreement;
|
|
(viii) any
agreement involving any current or former officer, director or
stockholder of the Company or an Affiliate thereof;
|
|
(ix) any
agreement under which the consequences of a default or termination
would reasonably be expected to have a Company Material Adverse
Effect;
|
|
(x) any
agreement which contains any provisions requiring the Company or
any Subsidiary to indemnify any other party; and
|
|
(xi) any
other agreement (or group of related agreements) either involving
more than $5,000.00 or not entered into in the Ordinary Course of
Business.
|
(b) The
Company has delivered to the Buyer a complete and accurate copy of
each material agreement listed in Section 2.13 or
Section 2.15 of the Disclosure Schedule. With respect to each
agreement so listed: (i) the agreement is legal, valid,
binding and enforceable and in full force and effect; (ii) the
agreement will continue to be legal, valid, binding and enforceable
and in full force and effect immediately following the Closing in
accordance with the terms thereof as in effect immediately prior to
the Closing; and (iii) neither the Company nor, to the
knowledge of the Company, any other party, is in breach or
violation of, or default under, any such agreement, and no event
has occurred, is pending or, to the knowledge of the Company, is
threatened, which, after the giving of notice, with lapse of time,
or otherwise, would constitute a breach or default by the Company
or, to the knowledge of the Company, any other party under such
agreement; (A) subject to in the case of sub-clause (i) and (ii),
bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and other similar laws of generally applicability
relating to or affecting creditors’ rights and to general
equity principles and (B) except as would not reasonably be
expected to have a Company Material Adverse Effect in the
aggregate.
|
2.16
Accounts Receivable . Except as listed in Section 2.16
of the Disclosure Schedule, all accounts receivable of the Company
reflected on the Most Recent Balance Sheet (other than those paid
since such date) are valid receivables subject to no setoffs or
counterclaims and are all current and collectible (within
90 days after the date on which it is due and payable), net of
the applicable reserve for bad debts as they were reflected on the
Most Recent Balance Sheet. A complete and accurate list of the
accounts receivable reflected on the Most Recent Balance Sheet,
showing the aging thereof, is included in Section 2.16 of the
Disclosure Schedule. All accounts receivable of the Company that
have arisen since the Most Recent Balance Sheet Date are valid
receivables subject to no setoffs or counterclaims and are
collectible (within 90 days after the date on which it first became
due and payable), net of a reserve for bad debts in an amount
proportionate to the reserve shown on the Most Recent Balance
Sheet. Except as listed in Section 2.16 of the Disclosure
Schedule, the Company has not received any written notice from an
account debtor stating that any account receivable is subject to
any contest, claim or setoff by such account debtor.
- 16 -
2.17
Powers of Attorney . There are no outstanding powers of
attorney executed on behalf of the Company.
2.18
Insurance . Section 2.18 of the Disclosure Schedule
lists each insurance policy (including fire, theft, casualty,
comprehensive general liability, workers compensation, business
interruption, environmental, product liability, errors and
omissions and automobile insurance policies and bond and surety
arrangements) to which the Company is a party, all of which are in
full force and effect. Such insurance policies are of the type and
in amounts customarily carried by organizations conducting
businesses or owning assets similar to those of the Company. There
is no material claim pending under any such policy as to which
coverage has been questioned, denied or disputed by the underwriter
of such policy. All premiums due and payable under all such
policies have been paid, the Company may not be liable for
retroactive premiums or similar payments, and the Company is
otherwise in compliance in all material respects with the terms of
such policies. The Company has no knowledge of any threatened
termination of, or premium increase with respect to, any such
policies. Such policies will cease to be in force and effect
following the Closing.
2.19
Litigation . Except as set forth on Section 2.19 of the
Disclosure Schedule, as of the date of this Agreement there is no
Legal Proceeding which is pending or has been threatened in writing
against the Company which (a) seeks either damages or
equitable relief or (b) in any manner challenges or seeks to
prevent, enjoin, alter or delay the transactions contemplated by
this Agreement. There are no judgments, orders or decrees
outstanding against the Company.
2.20
Warranties . No product or service manufactured, sold,
leased, licensed or delivered by the Company is subject to any
guaranty, warranty, right of return, right of credit or other
indemnity other than (i) the applicable standard terms and
conditions of sale or lease of the Company, which are set forth in
Section 2.20 of the Disclosure Schedule; and
(ii) manufacturers’ warranties for which the Company
does not have any liability. Section 2.20 of the Disclosure
Schedule sets forth the aggregate expenses incurred by the Company
in fulfilling its obligations under its guaranty, warranty, right
of return and indemnity provisions during each of the fiscal years
and the interim period covered by the Financial Statements; and the
Company does not know of any reason why such expenses should
significantly increase as a percentage of sales in the
future.
2.21
Employees . Section 2.21 of the Disclosure Schedule
contains a list of all employees of the Company, along with the
position and the annual rate of compensation of each such person.
Section 2.21 of the Disclosure Schedule contains the names of
all of the employees of the Company who are parties to a
non-competition or non-solicitation agreement with the Company.
Each current employee of the Company has entered into an Employee
Confidentiality Agreement in the form attached to Section 2.21
of the Disclosure Schedule. All of the agreements referenced in the
two preceding sentences will continue to be legal, valid, binding
and enforceable and in full force and effect immediately following
the Closing in accordance with the terms thereof as in effect
immediately prior to the Closing. Section 2.21 of the
Disclosure Schedule contains a list of all employees of the Company
who are not citizens of the United States of America. As of the
date hereof, to the knowledge of the Company, no key employee or
group of employees has any plans to terminate employment with the
Company.
- 17 -
(a) The
Company is not a party to or bound by any collective bargaining
agreement, nor has it experienced any strikes, slowdown, lockout,
grievances, claims of unfair labor practices or other collective
bargaining disputes. The Company has no knowledge of any
organizational effort made or threatened, either currently or
within the past two years, by or on behalf of any labor union with
respect to employees of the Company.
|
(b) The
Company has complied and is in compliance in all material respects
with all applicable laws relating to employment and labor matters,
including any provision thereof relating to wages, hours of work,
vacation pay, overtime pay, occupational health and safety and
conditions of employment.
|
(c) The
Company is not subject to any claim for wrongful dismissal,
constructive dismissal or any other claim, complaint or litigation
relating to employment discrimination or termination of employment
of any of its employees or former employees or relating to any
failure to hire a candidate for employment.
|
(d) There
is no order pursuant to any law requiring the taking of any action
or the refraining from taking any action in respect of any employee
or former employee of the Company.
|
(e) There
are no outstanding loans made by the Company to any employee or
former employee of the Company (for greater certainly, travel
advances or advances against commission of less than $1000.00 are
not considered as a loan for the purposes of this
paragraph).
|
(f) To
the Seller’s actual knowledge (without inquiry), no employee
of the Company has any plans to terminate his or her employment
with the Company.
|
2.22
Employee Benefit . Section 2.22(a) of the Disclosure
Schedule contains a complete and accurate list of all Company
Plans. Complete and accurate copies of (i) all Company Plans
which have been reduced to writing, (ii) written summaries of
all unwritten Company Plans, (iii) all related trust
agreements, insurance contracts and summary plan descriptions, and
(iv) all annual reports filed with a Governmental Entity and
(for all funded plans) all plan financial statements for the last
five plan years for each Company Plan, if applicable for such plan,
have been delivered to the Buyer.
(a) Each
Company Plan has been administered in all material respects in
accordance with its terms and the Company has in all material
respects met its obligations with respect to each Company Plan and
has made all required contributions thereto. The Company and each
Company Plan are in compliance in all material respects with all
provisions of applicable law. All filings and reports as to each
Company Plan required to have been submitted to any Governmental
Entity have been duly submitted. No Company Plan has assets that
include securities issued by the Company or any
Affiliate.
|
- 18 -
(b) There
are no Legal Proceedings (except claims for benefits payable in the
normal operation of the Company Plans and proceedings with respect
to qualified domestic relations orders) against or involving any
Company Plan or asserting any rights or claims to benefits under
any Company Plan that could give rise to any material
liability.
|
(c) All
the Company Plans that are intended to be registered have received
determination letters from the applicable taxing authorities to the
effect that such Company Plans are registered, the plans and the
trusts related thereto are exempt from income taxes under
applicablelaws, no such determination letter has been revoked and
revocation has not been threatened, no such Company Plan has been
amended since the date of its most recent determination letter or
application therefor in any respect, and no act or omission has
occurred that would adversely affect its qualification or
materially increase its cost.
|
(d) There
are no unfunded obligations under any Company Plan providing
benefits after termination of employment to any employee of the
Company (or to any beneficiary of any such employee), including,
but not limited to, retiree health coverage and deferred
compensation. The assets of each Company Plan which is funded are
reported at their fair market value on the books and records of
such Company Plan.
|
(e) No
act or omission has occurred and no condition exists with respect
to any Company Plan that would subject the Company or any Affiliate
or Company Plan to (i) any material fine, penalty, tax or liability
of any kind imposed under any law, or (ii) any contractual
indemnification or contribution obligation protecting any
fiduciary, insurer or service provider with respect to any Company
Plan.
|
(f) Each
Company Plan is amendable and terminable unilaterally by the
Company at any time without liability or expense to the Company or
such Company Plan as a result thereof (other than for benefits
accrued through the date of termination or amendment and reasonable
administrative expenses related thereto), and no Company Plan, plan
documentation or agreement, summary plan description or other
written communication distributed generally to employees by its
terms prohibits the Company from amending or terminating any such
Company Plan.
|
(g) Section 2.22(g)
of the Disclosure Schedule discloses each: (i) agreement with
any stockholder, director, executive officer or other key employee
of the Company (A) the benefits of which are contingent, or
the terms of which are altered, upon the occurrence of a
transaction involving the Company of the nature of any of the
transactions contemplated by this Agreement; (B) providing any
term of employment or compensation guarantee; or (C) providing
severance benefits, notices of termination, change of control
awards or other benefits after the termination of employment of
such director, executive officer or key employee;
(ii) agreement or plan binding the Company, including any
stock option plan, stock appreciation right plan, restricted stock
plan, stock purchase plan, severance benefit plan or Company Plan,
any of the benefits of which will be increased, or the vesting of
the benefits of which will be accelerated, by the occurrence of any
of the transactions contemplated by this Agreement or the value of
any of the benefits of which will be calculated on the basis of any
of the transactions contemplated by this Agreement.
|
- 19 -
(h) Section2.22(h)
of the Disclosure Schedule sets forth the policy of the Company
with respect to accrued vacation, accrued sick time and earned time
off and the amount of such liabilities as of the Most Recent
Balance Sheet Date.
|
(i) No
Company Plan provides for a payment to an employee as a result of a
change in control of the Company or the transfer of his employment
from his current employer to the Company or an Affiliate
thereof.
|
2.23
Legal Compliance . The Company is currently conducting, and
has at all times since January 1, 2005 conducted, its businesses in
compliance with each applicable law (including rules and
regulations thereunder) of any federal, state, local or foreign
government, or any Governmental Entity, except for any violations
or defaults that, individually or in the aggregate, has not had and
would not reasonably be expected to have a Company Material Adverse
Effect. The Company has not received any notice or communication
from any Governmental Entity alleging noncompliance with any
applicable law, rule or regulation.
2.24
Customers and Suppliers . Section 2.24 of the
Disclosure Schedule sets forth a list of (a) each customer that,
and each school or university whose students, accounted for more
than 5% of the consolidated revenues of the Company during the last
full fiscal year or the interim period through the Most Recent
Balance Sheet Date and the amou
|